LI-YU, Julie T.

LI-YU, Julie T.

Assoc. Prof Julie Li-Yu, MD, received her degree in B.Sc. Medical Technology under the College of Pharmacy from the University of Santo Tomas in 1985 and Doctor of Medicine in the same institution in 1990. She underwent residency training in Internal Medicine at the Chinese General Hospital and Medical Center in 1996 and finished fellowship training in Adult Rheumatology and Clinical Immunology at UST Hospital in 1999. After the fellowship, she went for a clinical research fellowship in 2000 on Gout and other crystal-associated arthritis at the University of Pennsylvania, USA, under Prof H. Ralph Schumacher through a grant from the Asia Pacific League of Associations for Rheumatology. After her return from UPenn, she joined the UST Faculty of Medicine and Surgery in 2001. She pursued a Master of Science in Public Health major in Biostatistics from the University of the Philippines Manila College of Public Health in 2006. She will be the Vice-Chair of the Asia Pacific Regional Panel of the International Society for Clinical Densitometry from 2023 to 2026. Her primary research interests are osteoporosis and other metabolic bone diseases, synovial crystal-associated arthropathies, and systemic lupus erythematosus, among other topics. She was conferred the Philippine College of Physicians (PCP) Exemplar in Clinical Research in 2014. She is the overall lead and convenor of the 2023 Philippine Clinical Practice Guidelines on osteoporosis among postmenopausal women and older men, which were approved and uploaded to the DOH-approved Clinical Practice Guidelines compendium. 

Updates

UST recognizes research achievements of faculty

UST recognizes research achievements of faculty

A total of 121 faculty members were recognized in the…

Assoc. Prof. Julie T.  Li-Yu, MD, MSPH, FPCP, FPRA

Department of Medicine | Faculty of Medicine and Surgery

jtli-yu@ust.edu.ph

ORCID

Academic Qualifications

Research Highlights

Research Interests

Academic Qualifications

Degrees

  • Master of Science in Public Health Major in Biostatistics, University of the Philippines – College of Public Health, 2006
  • Doctor of Medicine, University of Santo Tomas – Manila, Philippines,1985-1990
  • Bachelor of Science in Medical Technology, University of Santo Tomas – Manila, Philippines, 1981-1985

Postgraduate Trainings  

  • Research Fellowship Training in Rheumatology, University of Pennsylvania, USA, 1999   
  • Fellowship in Rheumatology and Clinical Immunology, University of Santo Tomas Hospital – Manila, Philippines, 1997-1999 
  • Residency in Internal Medicine, Chinese General Hospital and Medical Center, 1994-1996 
  • Medical Internship, Chinese General Hospital and Medical Center, 1992 

Research Highlights

  • She is actively involved in national (OSPFI, PRA, PCP, FNRI) and international organizations (APLAR, AFOS, ISCD, APCO), with primary aim of strengthening ties and collaborating with colleagues in research works and projects focusing on crystal-associated arthropathies especially gouty arthritis and metabolic bone disease inclosteoporosis and sarcopenia. She is the author of Chapter 25.3 Metabolic Disorders of the Bone – Osteoporosis and co-author of Chapter 25.4 Autoimmune Conditions – Rheumatoid Arthritis – in the recently launched 1st edition of the Philippine College of Physicians Textbook of Internal Medicine. She just finished leading the 2023 Osteoporosis clinical practice guidelines (CPG) taskforce members in finalizing the manuscript that was approved and endorsed on January 2024 by the National Practice Guidelines Program Secretariat as one of the DOH-approved CPG under the Universal Health Care Law. She is currently working on establishing normative database on trabecular bone score among generally healthy Filipino males and females. TBS is an analytical tool that captures trabecular microarchitecture in greater details than the standard lumbar spinebone mineral density (BMD). This tool will be used to complement results generated in the standard BMD results in the adult population. She is also part of the technical working group that laid the ground works on the 2024 hyperuricemia and gout CPG.

Research Interests

  • Rheumatology and Osteoporosis 
  • Medical Education

Courses Handled

Major Recognitions

Professional Activities

Courses Handled

  • Medicine 1 – Physical Diagnosis (2nd year Medical Students)
  • Medicine 2 (3rd year Medical Students)
  • Medicine 3 – Clerkship (4th year Medical Students)

Major Recognitions

  • Philippine College of Physicians Exemplar in Clinical Research, 2014
  • Silver Series Awardee (A.Y. 2020-2022) in Research, UST Office of Vice-Rector for Research and Innovation

Professional Activities

Academic Appointment 

  • Professor 5, Department of Medicine, UST Faculty of Medicine & Surgery

Administrative Appointments/Positions 

  • Chief, Section of Rheumatology, UST Faculty of Medicine & Surgery, 2020
  • Chief, Section of Rheumatology, Chinese General Hospital and Medical Center, since 2004
  • Head, Rheumatology Center, UST Hospital, since 2006
  • Chair, Department of Medical Education and Research, Chinese General Hospital and Medical Center, since 2016
  • Vice-Chair, Asia Pacific Panel International Society for Clinical Densitometry, 2023-2025
  • Chair, Philippine Rheumatology Association Osteoporosis Special Interest Group 

Past Positions  

  • President, Philippine Rheumatology Association, 2018-2020
  • President, Osteoporosis Society of the Philippines Foundation, Inc., 2017-2021
  • Chair, Institutional Review Board, Chinese General Hospital and Medical Center, August 2015-March 2016 

Professional Affiliations

  • Life Fellow, Philippine College of Physicians
  • Fellow, Philippine Rheumatology Association
  • Visiting Lecturer, Chinese General Hospital College of Medicine 

Hospital Affiliations 

  • Active Consultant, UST Hospital
  • Active Consultant, Chinese General Hospital and Medical Center

Selected Publications

Selected Publications

  • Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? Li-Yu J, Clayburne G, Sieck M, Beutler A, Rull M, Eisner E, Schumacher Jr HR. Journal of Rheumatology 2001;28:577-802.
  • Validation of OSTA among the Filipino population. Li-Yu J, Llamado LJQ, Torralba TP. Osteoporosis International 2005; 16:1789-17933.
  • Relationship of gout and hyperuricemia in cardiovascular and renal morbidity:2003 National Nutrition and Health Survey (NNHeS). Li-Yu J. Phil J Internal Medicine 2008;46:279-2854.
  • The Asian Audit – Epidemiology, Costs and Burden of Osteoporosis in Asia (www.iofbonehealth.org) Li-Yu J, dela Rosa M, Bonifacio L5.
  • Philippine Clinical Practice Guidelines for the Management of Gout. Li-Yu J, Salido EO, Manahan S, Lichauco JJL, Lorenzo P, Raso APP, Roberto LC, Santos Estrella P, Maceda LM. Phil J Int Med 2008 (JulAugust);46:165-1736.
  • A Phase 3, Randomized, Double-blind, Multicenter Active Controlled Trial to evaluate the safety and efficacy of Celecoxib and Indomethacin in the treatment of moderate to severe acute gouty arthritis Schumacher HR, Berger MF, Li-Yu J, Perez-Ruiz F, Burgos Vargas R, Li C. Journal of Rheumatology 2012:39;1859-18667.
  • Intervention thresholds to identify postmenopausal women with high fracture risk: a study based on the Philippines FRAX model. Li-Yu J, Lekamwasam S.Osteoporosis and Sarcopenia 2021;7:98-1028. 2021
  • APLAR Clinical Practice Guideline for treatment of gout. JPLorenzo, MHMZ Sollano, EO Salido, JLi-Yu, S Tankeh-Torres, IAR Wulansari Manuaba, MdMujibur Rahman, Binoy Paul, Mo Yin Mok, Monika de Silva, et al. International Journal of Rheumatic /diseases 2022;25:7-20.doi:10.1111/1756-185X.14266.